Rachael is a writer and environmental consultant who advises nonprofits and foundations on climate change. With an expertise in tropical forests, Rachael has conducted fieldwork in the Brazilian and Ecuadorian Amazon, Borneo, Uganda and elsewhere. After almost a decade in climate policy, Rachael has turned her attention to the spiritual implications of our current ecological crises. Rachael stumbled into psychedelics as a participant in a psilocybin clinical trial for major depression. Her writing excavates the potential risks, rewards, and societal implications of medicalizing and commercializing mysticism. Her work interrogates the intersection of the mystical and the moral, and envisions the role of non-ordinary states of consciousness in current and future forms of religion. Rachael explores these themes as a Junior Fellow at Harvard University's Center for the Study of World Religions.
June 26, 2017
This is part 1 of a 3-part series that follows the story of scientist, chemist, and fugitive, Robert Widdowson. During the 1980's Widdowson manufactured the MDMA analogue MDHA in Santa Fe, New Mexico until he was arrested and charged under the Federal Analogues Act. This is his story.
June 27, 2017
This is part 2 of a 3-part series that follows the story of scientist, chemist, and fugitive, Robert Widdowson. During the 1980's Widdowson manufactured the MDMA analogue MDHA in Santa Fe, New Mexico until he was arrested and charged under the Federal Analogues Act.
June 28, 2017
This is part 3 of a 3-part series that follows the story of scientist, chemist, and fugitive, Robert Widdowson. During the 1980's Widdowson manufactured the MDMA analogue MDHA in Santa Fe, New Mexico until he was arrested and charged under the Federal Analogues Act.
July 5, 2017
If neither the state nor defenders of our continued drug policies can provide a rational justification for the continued practice of incarcerating drug users, then the use of punishment by the state against drug users is morally unjustified.
July 12, 2017
We must remember how in less than two decades, an open internet enabled us to bridge some deep cultural divides, dismantle three-quarters of a century worth of drug propaganda, crowdsource massive databases of drug information, and crowdfund millions of dollars for FDA-approved research on psychedelics.
July 13, 2017
The Czech Psychedelic Society is creating the Czech version of Zendo Project and KosmiCare.
July 25, 2017
There’s an emerging public, political, and scientific consensus that otherwise-law-abiding people should not be arrested simply for using or possessing a drug.
July 26, 2017
Psychedelic therapy has the potential to ignite a paradigm shift within our culture by enabling us to reframe complex social problems as manifestations of trauma.
August 1, 2017
After getting off my long dependence on anti-depressants, I found myself feeling open to natural therapies.
August 8, 2017
First, the entire premise—that Schedule I status is the primary obstacle to research—is flat-out wrong.